ID
28372
Description
Investigator-initiated prospective randomized multicentre study to uncover the true burden of paroxysmal atrial fibrillation in a representative population of acute stroke patients without known atrial fibrillation. https://clinicaltrials.gov/ct2/show/NCT02204267?term=NCT02204267&rank=1. Sponsor: Charite University, Berlin, Germany; Collaborator: Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma; Information provided by (Responsible Party): Matthias Endres, Charite University, Berlin, Germany
Link
https://clinicaltrials.gov/ct2/show/NCT02204267?term=NCT02204267&rank=1
Keywords
Versions (1)
- 1/8/18 1/8/18 -
Copyright Holder
Charite University, Berlin, Germany
Uploaded on
January 8, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Criteria MonDAFIS Atrial Fibrillation in Ischemic Stroke NCT02204267
Eligibility Criteria MonDAFIS Atrial Fibrillation in Ischemic Stroke NCT02204267
Description
Exclusion Criteria
Description
Known atrial fibrillation
Data type
boolean
Description
Atrial fibrillation detected admission
Data type
boolean
Description
Atrial fibrillation detected prior study enrollment
Data type
boolean
Description
Life expectancy less than 1 year
Data type
boolean
Description
Life expectancy less than 1 month
Data type
boolean
Description
Indication for oral anticoagulation
Data type
boolean
Description
NIHSS score
Data type
boolean
Description
interventional trial
Data type
boolean